NMD4C and MDC Announce Recipients of Post-doctoral Research Fellowships

The Neuromuscular Disease Network for Canada (NMD4C) together with Muscular Dystrophy Canada (MDC) are excited to announce the recipients of a funding competition, which awarded national post-doctoral fellowships in neuromuscular research. This competition saw many incredible applicants and involved a thorough and extensive review by leading Canadian neuromuscular researchers to ensure the most promising and top-ranked researchers received the funding.

The fellowship provides salary support for early-career scientists to conduct postdoctoral studies in a laboratory focused on research of NMDs. Successful applicants will receive $40,000 in funding over a one-year period.

“This initiative will assist with training and education for the next generation of neuromuscular researchers and strengthens the biomedical infrastructure to build neuromuscular research capacity in Canada. For our clients, this means we are investing in the sustainability of neuromuscular research which brings us one step closer to finding cures.”

Stacey Lintern, CEO of Muscular Dystrophy Canada

 

“The fellowships will provide opportunities for early-career scientists to pursue exciting research in NMDs. Reducing barriers to practice in neuromuscular research is integral in allowing researchers to build a sustainable career in the field, and we are pleased to partner with Muscular Dystrophy Canada in providing these opportunities.”

Dr. Rashmi Kothary, Steering Committee Member of the NMD4C

 

Post-doctoral research fellowship recipients:

Emanuela Pannia, PhD
Research Institute, Hospital for Sick Children

Fellowship recipient Emanuela PanniaPost-doctoral Supervisor: James Dowling, MD, PhD, Clinician and Senior Scientist, The Hospital for Sick Children
Title of Research: Determining the molecular mechanisms and environmental modifiers of progressive liver disease in X-linked myotubular myopathy.
Overview: The goal of this study is to identify the cause of liver disease in X-linked myotubular myopathy (XLMTM) and the effects of diet and the immune system on its development. This study will be the first to identify causes of liver disease in XLMTM and discover new therapies to help children with this devastating disease.

 

Rebecca Robertson, PhD
McGill University

Post-doctoral Supervisor: Dr. Natasha Chang, Assistant Professor, McGill University
Title of research: The role of CARM1 in satellite cell dysfunction in Duchenne muscular dystrophy (DMD)
Overview: This project aims to fully assess issues in protein quality in DMD muscle stem cells through a variety of methods. This study will also explore how changes to CARM1 can impact the function of muscle stem cells and how they contribute to muscle repair. The ultimate goal of this work is to provide possible of treatment for DMD through these stem cells.

 

These fellows exemplify the excellence of future generations of researchers. Generous supporters of MDC made this funding competition possible. Thank you for making a difference and investing in the future of neuromuscular research.

postdocfellowship-updated

Read next...

AGAMREE (vamorolone) Approved treatment for DMD in Canada

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.

Website - SBMA published on CMAJ.png

New Best Practice Recommendations for SBMA Care in Canada

Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!

2025 NMD4C ANNUAL MEETING

Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting

On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.

2025 Clinical Summer School

NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders

On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.

2026 Neuromuscular Postdoc Research Fellowship Competition

2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!

Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)

Clinical Fellowship Awardees

Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients

We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.